News

Dr. Christian Steidl, senior scientist and Executive Director, Research at BC Cancer, is the recipient of a 2025 Operating Grant in Blood Cancer, co-funded by AstraZeneca Canada and the Leukemia & Lymphoma Society of Canada.

The research is dedicated to developing innovative tools for precise and efficient gene editing in B-cell lymphomas. By targeting the underlying genetic causes of cancer, this work paves the way for novel treatment strategies and opens new possibilities for patients living with B-cell lymphoma.

BC Cancer senior scientist, Dr. Alexander Wyatt, has been appointed the UBC President’s Excellence Chair in Precision Oncology by the UBC Faculty of Medicine. 

With renewed support from a $5.5-million Terry Fox New Frontiers Program Project Grant, leading researchers from BC Cancer and the University of British Columbia (UBC) are determined to change how we understand and treat sarcomas – rare and aggressive bone and soft tissue cancers that disproportionately affect young people.

Two Postdoctoral Fellows in the Evgin Lab at the BC Cancer Research Institute are the recipients of the 2025 Research Trainee Awards from Michael Smith Health Research BC.

When Dr. Jennifer Ritonja joined BC Cancer in July 2025 as a scientist, she set out to advance how we detect and prevent cancer in women. A trained epidemiologist, her research focuses on identifying early indicators of cancer in women, particularly for breast and ovarian cancers. 

In a national first, a team of top Canadian cancer researchers, including BC Cancer distinguished scientist Dr. Poul Sorensen, is joining forces with world-class US scientists at leading cancer institutes south of the border to tackle together the challenges of osteosarcoma (bone cancer), or what is sometimes called the Terry Fox cancer.